Low dose simulation formula and short dose specification for the treatment of behavioral keratose

摘要

1-isobutyl-1h-imidazole [4,5-c] - quinine-4-amin or 1 - (2-methylpropyl) - 1h-imidazole [4,5-c] quinine-4-amin (4,5-c) imidazole [4,4-c] imidazole-4-amin, i.e. imiquimod, is used for the treatment of short-term active adhesives, 1. 5% of aldrin currently on the market as authorized by the food and Drug Administration (FDA); More specificallyIt shows and describes a low-dose formulation of pyridine diphenyl ether to provide an effective dose of pyridine diphenyl ether for the treatment of active corneas with acceptable safety and dose specifications.RTOS AND MORE CONVENIENT FOR USE BY THE PATIENT THAN THE DOSAGE REGIME CURRENTLY AUTHORIZED BY THE UNITED STATES ADMINISTRATION OF FOODS AND DRUGS ("FDA") FOR THE 5% IMIQUIMOD CREAM TO TREAT ACTINIC KERATOSIS.